Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

Natural killer cells (NK) are essential for the elimination of resistant acute myeloid and acute lymphoblastic leukemia (AML and ALL) cells. NK cell-based immunotherapies have already successfully entered for clinical trials, but limitations due to immune escape mechanisms were identified. Therefore...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Kloess, Stephan, Ede Valverde da Silva, Alessa, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, Pogge von Strandmann, Elke, Köhl, Ulrike
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596090/
https://ncbi.nlm.nih.gov/pubmed/28943878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados